文章摘要
高博,刘彬,孙小馨,马丽佳,阮征,杨娟,牛华英.部分药品企业受理消费者不良反应报告情况调查[J].中国药事,2018,32(2):295-298
部分药品企业受理消费者不良反应报告情况调查
Investigation on the Situation of Answering the Adverse Drug Reaction Reporting from Consumers of Some Pharmaceutical Companies
投稿时间:2017-05-21  
DOI:10.16153/j.1002-7777.2018.02.023
中文关键词: 药品生产企业  消费者  药品不良反应
英文关键词: pharmaceutical company  consumer  adverse drug reaction
基金项目:
作者单位E-mail
高博 辽宁大学, 沈阳 110036  
刘彬 辽宁大学, 沈阳 110036 liubin@lnu.edu.cn 
孙小馨 辽宁大学, 沈阳 110036  
马丽佳 辽宁大学, 沈阳 110036  
阮征 辽宁大学, 沈阳 110036  
杨娟 辽宁大学, 沈阳 110036  
牛华英 济南大成医药发展有限公司, 济南 250100 niuhuaying@sohu.com 
摘要点击次数: 1268
全文下载次数: 622
中文摘要:
      目的:为完善和促进我国药品不良反应(ADR)监测工作提供依据。方法:随机选取500家市售企业产品,采用拨打药品生产企业包装上的联系电话方式,对企业受理消费者ADR报告情况进行调查。结果:仅有23%产品包装上的标注电话有人接听,75%企业包装上标注的电话号码无人接听,7家企业的联系方式竟然是空号。结论:企业电话接通率普遍较低,说明企业对于该渠道接受消费者ADR信息的重视程度不够。
英文摘要:
      Objective: To provide a basis for improving and promoting the monitoring of adverse drug reaction (ADR) in China. Methods: 500 commercial products of pharmaceutical companies were randomly selected and the situation of answering the ADR reporting from consumers was investigated by dialing the contact phone numbers printed on the package. Results: Only 23% phone numbers printed on the package were answered, 75% phone numbers printed on the package were not answered, and 7 phone numbers were not in use. Conclusion: The ratio of answering was generally low, indicating that pharmaceutical companies did not pay enough attention to this way of answering ADR reporting from consumers.
查看全文   查看/发表评论  下载PDF阅读器
关闭